Stevanato Group S.p.A. (NYSE:STVN) Shares Bought by First Bank & Trust

First Bank & Trust raised its holdings in Stevanato Group S.p.A. (NYSE:STVN) by 7.3% in the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 15,145 shares of the company’s stock after acquiring an additional 1,036 shares during the quarter. First Bank & Trust’s holdings in Stevanato Group were worth $330,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other institutional investors and hedge funds also recently bought and sold shares of STVN. Hardy Reed LLC lifted its holdings in Stevanato Group by 8.2% in the 3rd quarter. Hardy Reed LLC now owns 11,077 shares of the company’s stock valued at $222,000 after acquiring an additional 840 shares during the last quarter. Lindenwold Advisors INC lifted its holdings in Stevanato Group by 13.5% in the 3rd quarter. Lindenwold Advisors INC now owns 11,930 shares of the company’s stock valued at $239,000 after acquiring an additional 1,415 shares during the last quarter. Raymond James Trust N.A. raised its holdings in Stevanato Group by 22.6% during the 3rd quarter. Raymond James Trust N.A. now owns 12,556 shares of the company’s stock worth $251,000 after buying an additional 2,317 shares during the period. Captrust Financial Advisors lifted its stake in Stevanato Group by 12.7% during the third quarter. Captrust Financial Advisors now owns 13,100 shares of the company’s stock valued at $262,000 after buying an additional 1,480 shares in the last quarter. Finally, SG Americas Securities LLC lifted its stake in Stevanato Group by 18.2% during the fourth quarter. SG Americas Securities LLC now owns 15,546 shares of the company’s stock valued at $339,000 after buying an additional 2,389 shares in the last quarter.

Stevanato Group Price Performance

NYSE STVN opened at €20.31 ($21.38) on Friday. The company has a 50 day simple moving average of €21.82 and a 200-day simple moving average of €20.53. The company has a debt-to-equity ratio of 0.22, a current ratio of 1.81 and a quick ratio of 1.21. The firm has a market capitalization of $6.15 billion, a price-to-earnings ratio of 43.21, a price-to-earnings-growth ratio of 7.07 and a beta of 0.56. Stevanato Group S.p.A. has a 52-week low of €16.56 ($17.43) and a 52-week high of €34.00 ($35.79).

Wall Street Analysts Forecast Growth

A number of analysts have commented on the stock. Wolfe Research assumed coverage on shares of Stevanato Group in a research note on Friday, December 13th. They set an “outperform” rating and a $28.00 price objective for the company. Morgan Stanley reaffirmed an “equal weight” rating and set a $23.00 price objective (down from $24.00) on shares of Stevanato Group in a research note on Tuesday, December 3rd. Finally, Bank of America upped their price objective on shares of Stevanato Group from $24.00 to $26.00 and gave the company a “buy” rating in a research note on Friday, December 13th. One research analyst has rated the stock with a hold rating and five have issued a buy rating to the stock. Based on data from MarketBeat, the company has a consensus rating of “Moderate Buy” and an average price target of €28.60 ($30.11).

Stevanato Group Profile

Stevanato Group S.p.A. engages in the design, production, and distribution of products and processes to provide integrated solutions for bio-pharma and healthcare industries in Europe, the Middle East, Africa, North America, South America, and the Asia Pacific. The company operates in two segments, Biopharmaceutical and Diagnostic Solutions; and Engineering.